Myosotis Investments
Overview
Myosotis Investments is a venture capital firm that focuses on catalyzing advancements in life sciences, with a particular focus on molecular diagnostics, by investing in companies that are reshaping healthcare.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Scinus Cell Expansion | Mar 2026 | Strategic | Lead |
| PamGene International BV | Apr 2026 | Series A | Lead |
| Idevax | Oct 2024 | Series A | Lead |
| Cyclomics B.V. | Jan 2026 | VC Round | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Myosotis Investments based?
Myosotis Investments is headquartered in Zeist, Netherlands.
When was Myosotis Investments founded?
Myosotis Investments was founded in 2024.
How many portfolio companies does Myosotis Investments have?
Myosotis Investments has 4 portfolio companies in Caplight's dataset.
What are some companies in Myosotis Investments's portfolio?
Portfolio companies visible on Caplight include Scinus Cell Expansion, PamGene International BV, Idevax, Cyclomics B.V..
What was Myosotis Investments's most recent investment shown here?
Myosotis Investments's most recent investment in this portfolio sample was in PamGene International BV in 2026.
What sectors does Myosotis Investments focus on?
Myosotis Investments focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does Myosotis Investments focus on?
Myosotis Investments typically invests at the Early stage.